Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry

Lobular neoplasia (LN) is a term that encompasses both lobular carcinoma in situ and atypical lobular hyperplasia. These lesions have been shown to constitute both risk indicators and nonobligate precursors of invasive breast cancer, they are relatively uncommon, and are most often identified in spe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of surgical pathology 2013-07, Vol.37 (7), p.e1-e11
Hauptverfasser: Dabbs, David J, Schnitt, Stuart J, Geyer, Felipe C, Weigelt, Britta, Baehner, Frederick L, Decker, Thomas, Eusebi, Vincenzo, Fox, Stephen B, Ichihara, Shu, Lakhani, Sunil R, Palacios, Jose, Rakha, Emad, Richardson, Andrea L, Schmitt, Fernando C, Tan, Puay-Hoon, Tse, Gary M, Vincent-Salomon, Anne, Ellis, Ian O, Badve, Sunil, Reis-Filho, Jorge S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e11
container_issue 7
container_start_page e1
container_title The American journal of surgical pathology
container_volume 37
creator Dabbs, David J
Schnitt, Stuart J
Geyer, Felipe C
Weigelt, Britta
Baehner, Frederick L
Decker, Thomas
Eusebi, Vincenzo
Fox, Stephen B
Ichihara, Shu
Lakhani, Sunil R
Palacios, Jose
Rakha, Emad
Richardson, Andrea L
Schmitt, Fernando C
Tan, Puay-Hoon
Tse, Gary M
Vincent-Salomon, Anne
Ellis, Ian O
Badve, Sunil
Reis-Filho, Jorge S
description Lobular neoplasia (LN) is a term that encompasses both lobular carcinoma in situ and atypical lobular hyperplasia. These lesions have been shown to constitute both risk indicators and nonobligate precursors of invasive breast cancer, they are relatively uncommon, and are most often identified in specimens taken for other reasons. Their incidence has increased in the last 2 decades, and novel variants, including a pleomorphic type, have been described. Loss of E-cadherin expression is recognized as a hallmark diagnostic feature of LN and invasive lobular carcinomas, and immunohistochemical (IHC) analysis using anti-E-cadherin antibodies has been proven to be a useful method to differentiate between lobular and ductal lesions. The frequent use of E-cadherin IHC analysis in routine diagnostic histopathology, however, has resulted in confusion with regard to the actual value of IHC with antibodies against E-cadherin and other proteins of the cadherin-catenin complex. This review provides an update on recent clinicopathologic and molecular data on LN and invasive lobular carcinoma and a discussion about the use and limitations of IHC with E-cadherin in diagnostic breast pathology.
doi_str_mv 10.1097/PAS.0b013e3182918a2b
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1417528742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1417528742</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3521-e3d5975a7589edc9d8b39f9a3850ec955e3ec7a623d63d6d79eadedfee22aa323</originalsourceid><addsrcrecordid>eNpdUG1LHDEQDlLxTtt_ICUf-2Wvedlcko96XFU4qqilH0N2M8uuZi9nslvx35utVwsOA8PMPC_wIHRKyYISLb_fnN0tSEUoB04V01RZVh2gORWcFfmvP6E5oaUsBFViho5TeiCEMkXZEZoxLoXWXM5RswnV6G3EPyHsvE2dxaHBQwv4PIJNA76FP13qBnD4dze0eN3v2oxKOGz_om6Dh4mxLlbWtRC7Lb7q-3Eb2i4NoW6hzzO-fEaHjfUJvuznCfr1Y32_uiw21xdXq7NNUXPBaAHcCS2FlUJpcLV2quK60ZYrQaDWQgCHWtol426Z20kN1oFrABizljN-gr696e5ieBohDSb71-C93UIYk6EllYIpWU7Q8g1ax5BShMbsYtfb-GIoMVPCJidsPiacaV_3DmPVg3sn_Yv0v-5z8APE9OjHZ4imBeuH1pCpSqkKlnWJzEsxXSh_BTvOiNE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1417528742</pqid></control><display><type>article</type><title>Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Dabbs, David J ; Schnitt, Stuart J ; Geyer, Felipe C ; Weigelt, Britta ; Baehner, Frederick L ; Decker, Thomas ; Eusebi, Vincenzo ; Fox, Stephen B ; Ichihara, Shu ; Lakhani, Sunil R ; Palacios, Jose ; Rakha, Emad ; Richardson, Andrea L ; Schmitt, Fernando C ; Tan, Puay-Hoon ; Tse, Gary M ; Vincent-Salomon, Anne ; Ellis, Ian O ; Badve, Sunil ; Reis-Filho, Jorge S</creator><creatorcontrib>Dabbs, David J ; Schnitt, Stuart J ; Geyer, Felipe C ; Weigelt, Britta ; Baehner, Frederick L ; Decker, Thomas ; Eusebi, Vincenzo ; Fox, Stephen B ; Ichihara, Shu ; Lakhani, Sunil R ; Palacios, Jose ; Rakha, Emad ; Richardson, Andrea L ; Schmitt, Fernando C ; Tan, Puay-Hoon ; Tse, Gary M ; Vincent-Salomon, Anne ; Ellis, Ian O ; Badve, Sunil ; Reis-Filho, Jorge S</creatorcontrib><description>Lobular neoplasia (LN) is a term that encompasses both lobular carcinoma in situ and atypical lobular hyperplasia. These lesions have been shown to constitute both risk indicators and nonobligate precursors of invasive breast cancer, they are relatively uncommon, and are most often identified in specimens taken for other reasons. Their incidence has increased in the last 2 decades, and novel variants, including a pleomorphic type, have been described. Loss of E-cadherin expression is recognized as a hallmark diagnostic feature of LN and invasive lobular carcinomas, and immunohistochemical (IHC) analysis using anti-E-cadherin antibodies has been proven to be a useful method to differentiate between lobular and ductal lesions. The frequent use of E-cadherin IHC analysis in routine diagnostic histopathology, however, has resulted in confusion with regard to the actual value of IHC with antibodies against E-cadherin and other proteins of the cadherin-catenin complex. This review provides an update on recent clinicopathologic and molecular data on LN and invasive lobular carcinoma and a discussion about the use and limitations of IHC with E-cadherin in diagnostic breast pathology.</description><identifier>ISSN: 0147-5185</identifier><identifier>EISSN: 1532-0979</identifier><identifier>DOI: 10.1097/PAS.0b013e3182918a2b</identifier><identifier>PMID: 23759937</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Biomarkers, Tumor - metabolism ; Breast Neoplasms - diagnosis ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Cadherins - genetics ; Cadherins - metabolism ; Carcinoma in Situ - diagnosis ; Carcinoma in Situ - genetics ; Carcinoma in Situ - metabolism ; Carcinoma, Ductal, Breast - diagnosis ; Carcinoma, Ductal, Breast - genetics ; Carcinoma, Ductal, Breast - metabolism ; Carcinoma, Lobular - diagnosis ; Carcinoma, Lobular - genetics ; Carcinoma, Lobular - metabolism ; Catenins - genetics ; Catenins - metabolism ; Diagnosis, Differential ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immunohistochemistry - methods ; Molecular Diagnostic Techniques</subject><ispartof>The American journal of surgical pathology, 2013-07, Vol.37 (7), p.e1-e11</ispartof><rights>2013 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3521-e3d5975a7589edc9d8b39f9a3850ec955e3ec7a623d63d6d79eadedfee22aa323</citedby><cites>FETCH-LOGICAL-c3521-e3d5975a7589edc9d8b39f9a3850ec955e3ec7a623d63d6d79eadedfee22aa323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23759937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dabbs, David J</creatorcontrib><creatorcontrib>Schnitt, Stuart J</creatorcontrib><creatorcontrib>Geyer, Felipe C</creatorcontrib><creatorcontrib>Weigelt, Britta</creatorcontrib><creatorcontrib>Baehner, Frederick L</creatorcontrib><creatorcontrib>Decker, Thomas</creatorcontrib><creatorcontrib>Eusebi, Vincenzo</creatorcontrib><creatorcontrib>Fox, Stephen B</creatorcontrib><creatorcontrib>Ichihara, Shu</creatorcontrib><creatorcontrib>Lakhani, Sunil R</creatorcontrib><creatorcontrib>Palacios, Jose</creatorcontrib><creatorcontrib>Rakha, Emad</creatorcontrib><creatorcontrib>Richardson, Andrea L</creatorcontrib><creatorcontrib>Schmitt, Fernando C</creatorcontrib><creatorcontrib>Tan, Puay-Hoon</creatorcontrib><creatorcontrib>Tse, Gary M</creatorcontrib><creatorcontrib>Vincent-Salomon, Anne</creatorcontrib><creatorcontrib>Ellis, Ian O</creatorcontrib><creatorcontrib>Badve, Sunil</creatorcontrib><creatorcontrib>Reis-Filho, Jorge S</creatorcontrib><title>Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry</title><title>The American journal of surgical pathology</title><addtitle>Am J Surg Pathol</addtitle><description>Lobular neoplasia (LN) is a term that encompasses both lobular carcinoma in situ and atypical lobular hyperplasia. These lesions have been shown to constitute both risk indicators and nonobligate precursors of invasive breast cancer, they are relatively uncommon, and are most often identified in specimens taken for other reasons. Their incidence has increased in the last 2 decades, and novel variants, including a pleomorphic type, have been described. Loss of E-cadherin expression is recognized as a hallmark diagnostic feature of LN and invasive lobular carcinomas, and immunohistochemical (IHC) analysis using anti-E-cadherin antibodies has been proven to be a useful method to differentiate between lobular and ductal lesions. The frequent use of E-cadherin IHC analysis in routine diagnostic histopathology, however, has resulted in confusion with regard to the actual value of IHC with antibodies against E-cadherin and other proteins of the cadherin-catenin complex. This review provides an update on recent clinicopathologic and molecular data on LN and invasive lobular carcinoma and a discussion about the use and limitations of IHC with E-cadherin in diagnostic breast pathology.</description><subject>Biomarkers, Tumor - metabolism</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Cadherins - genetics</subject><subject>Cadherins - metabolism</subject><subject>Carcinoma in Situ - diagnosis</subject><subject>Carcinoma in Situ - genetics</subject><subject>Carcinoma in Situ - metabolism</subject><subject>Carcinoma, Ductal, Breast - diagnosis</subject><subject>Carcinoma, Ductal, Breast - genetics</subject><subject>Carcinoma, Ductal, Breast - metabolism</subject><subject>Carcinoma, Lobular - diagnosis</subject><subject>Carcinoma, Lobular - genetics</subject><subject>Carcinoma, Lobular - metabolism</subject><subject>Catenins - genetics</subject><subject>Catenins - metabolism</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Immunohistochemistry - methods</subject><subject>Molecular Diagnostic Techniques</subject><issn>0147-5185</issn><issn>1532-0979</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUG1LHDEQDlLxTtt_ICUf-2Wvedlcko96XFU4qqilH0N2M8uuZi9nslvx35utVwsOA8PMPC_wIHRKyYISLb_fnN0tSEUoB04V01RZVh2gORWcFfmvP6E5oaUsBFViho5TeiCEMkXZEZoxLoXWXM5RswnV6G3EPyHsvE2dxaHBQwv4PIJNA76FP13qBnD4dze0eN3v2oxKOGz_om6Dh4mxLlbWtRC7Lb7q-3Eb2i4NoW6hzzO-fEaHjfUJvuznCfr1Y32_uiw21xdXq7NNUXPBaAHcCS2FlUJpcLV2quK60ZYrQaDWQgCHWtol426Z20kN1oFrABizljN-gr696e5ieBohDSb71-C93UIYk6EllYIpWU7Q8g1ax5BShMbsYtfb-GIoMVPCJidsPiacaV_3DmPVg3sn_Yv0v-5z8APE9OjHZ4imBeuH1pCpSqkKlnWJzEsxXSh_BTvOiNE</recordid><startdate>201307</startdate><enddate>201307</enddate><creator>Dabbs, David J</creator><creator>Schnitt, Stuart J</creator><creator>Geyer, Felipe C</creator><creator>Weigelt, Britta</creator><creator>Baehner, Frederick L</creator><creator>Decker, Thomas</creator><creator>Eusebi, Vincenzo</creator><creator>Fox, Stephen B</creator><creator>Ichihara, Shu</creator><creator>Lakhani, Sunil R</creator><creator>Palacios, Jose</creator><creator>Rakha, Emad</creator><creator>Richardson, Andrea L</creator><creator>Schmitt, Fernando C</creator><creator>Tan, Puay-Hoon</creator><creator>Tse, Gary M</creator><creator>Vincent-Salomon, Anne</creator><creator>Ellis, Ian O</creator><creator>Badve, Sunil</creator><creator>Reis-Filho, Jorge S</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201307</creationdate><title>Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry</title><author>Dabbs, David J ; Schnitt, Stuart J ; Geyer, Felipe C ; Weigelt, Britta ; Baehner, Frederick L ; Decker, Thomas ; Eusebi, Vincenzo ; Fox, Stephen B ; Ichihara, Shu ; Lakhani, Sunil R ; Palacios, Jose ; Rakha, Emad ; Richardson, Andrea L ; Schmitt, Fernando C ; Tan, Puay-Hoon ; Tse, Gary M ; Vincent-Salomon, Anne ; Ellis, Ian O ; Badve, Sunil ; Reis-Filho, Jorge S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3521-e3d5975a7589edc9d8b39f9a3850ec955e3ec7a623d63d6d79eadedfee22aa323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biomarkers, Tumor - metabolism</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Cadherins - genetics</topic><topic>Cadherins - metabolism</topic><topic>Carcinoma in Situ - diagnosis</topic><topic>Carcinoma in Situ - genetics</topic><topic>Carcinoma in Situ - metabolism</topic><topic>Carcinoma, Ductal, Breast - diagnosis</topic><topic>Carcinoma, Ductal, Breast - genetics</topic><topic>Carcinoma, Ductal, Breast - metabolism</topic><topic>Carcinoma, Lobular - diagnosis</topic><topic>Carcinoma, Lobular - genetics</topic><topic>Carcinoma, Lobular - metabolism</topic><topic>Catenins - genetics</topic><topic>Catenins - metabolism</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Immunohistochemistry - methods</topic><topic>Molecular Diagnostic Techniques</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dabbs, David J</creatorcontrib><creatorcontrib>Schnitt, Stuart J</creatorcontrib><creatorcontrib>Geyer, Felipe C</creatorcontrib><creatorcontrib>Weigelt, Britta</creatorcontrib><creatorcontrib>Baehner, Frederick L</creatorcontrib><creatorcontrib>Decker, Thomas</creatorcontrib><creatorcontrib>Eusebi, Vincenzo</creatorcontrib><creatorcontrib>Fox, Stephen B</creatorcontrib><creatorcontrib>Ichihara, Shu</creatorcontrib><creatorcontrib>Lakhani, Sunil R</creatorcontrib><creatorcontrib>Palacios, Jose</creatorcontrib><creatorcontrib>Rakha, Emad</creatorcontrib><creatorcontrib>Richardson, Andrea L</creatorcontrib><creatorcontrib>Schmitt, Fernando C</creatorcontrib><creatorcontrib>Tan, Puay-Hoon</creatorcontrib><creatorcontrib>Tse, Gary M</creatorcontrib><creatorcontrib>Vincent-Salomon, Anne</creatorcontrib><creatorcontrib>Ellis, Ian O</creatorcontrib><creatorcontrib>Badve, Sunil</creatorcontrib><creatorcontrib>Reis-Filho, Jorge S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dabbs, David J</au><au>Schnitt, Stuart J</au><au>Geyer, Felipe C</au><au>Weigelt, Britta</au><au>Baehner, Frederick L</au><au>Decker, Thomas</au><au>Eusebi, Vincenzo</au><au>Fox, Stephen B</au><au>Ichihara, Shu</au><au>Lakhani, Sunil R</au><au>Palacios, Jose</au><au>Rakha, Emad</au><au>Richardson, Andrea L</au><au>Schmitt, Fernando C</au><au>Tan, Puay-Hoon</au><au>Tse, Gary M</au><au>Vincent-Salomon, Anne</au><au>Ellis, Ian O</au><au>Badve, Sunil</au><au>Reis-Filho, Jorge S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry</atitle><jtitle>The American journal of surgical pathology</jtitle><addtitle>Am J Surg Pathol</addtitle><date>2013-07</date><risdate>2013</risdate><volume>37</volume><issue>7</issue><spage>e1</spage><epage>e11</epage><pages>e1-e11</pages><issn>0147-5185</issn><eissn>1532-0979</eissn><abstract>Lobular neoplasia (LN) is a term that encompasses both lobular carcinoma in situ and atypical lobular hyperplasia. These lesions have been shown to constitute both risk indicators and nonobligate precursors of invasive breast cancer, they are relatively uncommon, and are most often identified in specimens taken for other reasons. Their incidence has increased in the last 2 decades, and novel variants, including a pleomorphic type, have been described. Loss of E-cadherin expression is recognized as a hallmark diagnostic feature of LN and invasive lobular carcinomas, and immunohistochemical (IHC) analysis using anti-E-cadherin antibodies has been proven to be a useful method to differentiate between lobular and ductal lesions. The frequent use of E-cadherin IHC analysis in routine diagnostic histopathology, however, has resulted in confusion with regard to the actual value of IHC with antibodies against E-cadherin and other proteins of the cadherin-catenin complex. This review provides an update on recent clinicopathologic and molecular data on LN and invasive lobular carcinoma and a discussion about the use and limitations of IHC with E-cadherin in diagnostic breast pathology.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>23759937</pmid><doi>10.1097/PAS.0b013e3182918a2b</doi></addata></record>
fulltext fulltext
identifier ISSN: 0147-5185
ispartof The American journal of surgical pathology, 2013-07, Vol.37 (7), p.e1-e11
issn 0147-5185
1532-0979
language eng
recordid cdi_proquest_miscellaneous_1417528742
source MEDLINE; Journals@Ovid Complete
subjects Biomarkers, Tumor - metabolism
Breast Neoplasms - diagnosis
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Cadherins - genetics
Cadherins - metabolism
Carcinoma in Situ - diagnosis
Carcinoma in Situ - genetics
Carcinoma in Situ - metabolism
Carcinoma, Ductal, Breast - diagnosis
Carcinoma, Ductal, Breast - genetics
Carcinoma, Ductal, Breast - metabolism
Carcinoma, Lobular - diagnosis
Carcinoma, Lobular - genetics
Carcinoma, Lobular - metabolism
Catenins - genetics
Catenins - metabolism
Diagnosis, Differential
Female
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry - methods
Molecular Diagnostic Techniques
title Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T01%3A03%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lobular%20Neoplasia%20of%20the%20Breast%20Revisited%20With%20Emphasis%20on%20the%20Role%20of%20E-Cadherin%20Immunohistochemistry&rft.jtitle=The%20American%20journal%20of%20surgical%20pathology&rft.au=Dabbs,%20David%20J&rft.date=2013-07&rft.volume=37&rft.issue=7&rft.spage=e1&rft.epage=e11&rft.pages=e1-e11&rft.issn=0147-5185&rft.eissn=1532-0979&rft_id=info:doi/10.1097/PAS.0b013e3182918a2b&rft_dat=%3Cproquest_cross%3E1417528742%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1417528742&rft_id=info:pmid/23759937&rfr_iscdi=true